This inventor holds 22 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Chimeric Antigen Receptors. Top assignees: Novartis Ag, University of Pennsylvania. Active years: 2017-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Brighton, MA (US) (2022)
- Shanghai, CN (2017 - 2024)
Company Filing History:
22 out of 3,978 
15 out of 2,665 
Years Active: 2017-2025
Areas of Expertise:
Title: **Qilong Wu: Innovator in Cancer Treatment and Virology**
Introduction
Qilong Wu, a prominent inventor based in Shanghai, China, has made significant contributions to the fields of cancer treatment and virology. With an impressive portfolio of 21 patents, his innovations reflect a strong commitment to advancing medical science and improving patient outcomes.
Latest Patents
Among Qilong Wu's latest patents is a groundbreaking invention titled "Treatment of cancer using humanized anti-BCMA chimeric antigen receptor." This innovation offers compositions and methods for treating diseases associated with the expression of BCMA. It also details chimeric antigen receptors (CAR) that are specific to BCMA, vectors encoding these CARs, and recombinant T cells that comprise the BCMA CAR. Furthermore, it includes methods for administering genetically modified T cells expressing a CAR that features a BCMA binding domain.
Another noteworthy patent is centered around "Polyomavirus neutralizing antibodies." This invention focuses on anti-VP1 antibodies, antibody fragments, and their potential uses for the prevention and treatment of polyoma virus infections and related diseases.
Career Highlights
Qilong Wu has had a diverse career, contributing his expertise to notable organizations such as Novartis AG and the University of Pennsylvania. His work in these esteemed institutions has further propelled his research and development efforts in the biomedical sector.
Collaborations
Throughout his career, Qilong Wu has collaborated with talented professionals in the field. Notables among his coworkers include Yongqiang Wang and Michael C. Milone, with whom he has shared insights and innovations that have enhanced his research outcomes.
Conclusion
Qilong Wu's contributions to science, particularly in cancer treatment and virology, underscore the importance of innovation in improving healthcare. With numerous patents to his name, he continues to influence the future of medical treatments and inspire upcoming inventors in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile